Karen Smith

Overview

Karen Smith received an average of $3M in total compensation, including $450K in salary, at Jazz Pharmaceuticals from 2015 to 2017.

Source: SEC filings on June 15, 2018 and June 20, 2017.

Related executives

We found 21 more executives who work or worked at Jazz Pharmaceuticals.

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

Daniel Swisher

Jazz Pharmaceuticals

President

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

Chris Tovey

Jazz Pharmaceuticals

Chief Operating Officer

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

Kim Sablich

Jazz Pharmaceuticals

Executive Vice President and General Manager, North America

Robert Ianonne

Jazz Pharmaceuticals

Chief Medical Officer

Robert Iannone

Jazz Pharmaceuticals

Executive Vice President, Research and Development

You may also like